Blood Pressure, Circulation Supplement to Enter Clinical Trial

August 10, 2011

Dietary supplements brand Nathans Natural announced that its Levodyn supplement will begin a Phase II clinical trial.

Dietary supplements brand Nathans Natural announced that its Levodyn supplement will begin a Phase II clinical trial to study its safety and efficacy in lowering blood pressure and improving blood circulation in mildly hypertensive subjects.

The company says that the trial will be a double-blind, randomized, placebo-controlled, parallel-group, multicenter study. It will be performed by contract research organization Vedic Lifesciences (Redwood Shores, CA).